0000000000603436

AUTHOR

Banu Acar

showing 3 related works from this author

Proceedings Of The 23Rd Paediatric Rheumatology European Society Congress: Part Two

2017

lcsh:Diseases of the musculoskeletal systemlcsh:RJ1-570lcsh:Pediatricslcsh:RC925-935Meeting Abstracts
researchProduct

The characteristics of patients with COVID-19-associated pediatric vasculitis: an international, multicenter study

2023

Objective: COVID-19-associated pediatric vasculitis, other than Kawasaki disease (KD)-like vasculitis in multisystem inflammatory syndrome in children (MIS-C), is very rare. This study sought to analyze the characteristics, treatment, and outcomes in patients with COVID-19-associated pediatric vasculitis (excluding KD-like vasculitis in MIS-C). Methods: The inclusion criteria were as follows: 1) age <18 years at vasculitis onset; 2) evidence of vasculitis; 3) evidence of SARS-CoV-2 exposure; and 4) ≤3 months between SARS-CoV-2 exposure and vasculitis onset. Patients with MIS-C were excluded. The features of the subset of patients in our cohort who had COVID-19-associated pediatric IgA vascu…

MaleVasculitis* / epidemiologyPediatric VasculitiAdolescentVasculitis* / etiologyKawasaki diseaseSARS-CoV-2ImmunologyCOVID-19MIS-CIgA Vasculitis* / epidemiologyImmunoglobulin AMucocutaneous Lymph Node Syndrome* / complicationsSettore MED/38 - Pediatria Generale E SpecialisticaRheumatologyCOVID-19* / complicationsIgA Vasculitis* / complicationsIgA Vasculitis* / drug therapyImmunology and AllergyHumansFemaleChild
researchProduct

Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part one

2017

lcsh:Diseases of the musculoskeletal systemlcsh:RJ1-570lcsh:Pediatricslcsh:RC925-935Meeting Abstracts
researchProduct